Related Experiment Video
Updated: May 26, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
[Radiation therapy versus chemoradiation as adjuvant treatment in high-risk endometrial cancer]
Ingrid Fumagalli1, Eric Leblanc, Philippe Nickers
1Centre Oscar-Lambret, département de radiothérapie-curiethérapie, Lille Cedex, France. fumagalli.ingrid@gmail.com
Abstract:
Endometrial cancer is a common malignancy. Management of these tumors depends on several risk factors such as FIGO staging, myometrial invasion, histology or pelvic lymph node involvement. According to those factors, low risk, intermediate and high risk groups were defined. A high risk endometrial cancer has a poorer prognostic and more risks of recurrence. Treatment of such disease should be more aggressive. However modalities of these treatments have not yet been clearly defined.

